Factory 99% Ibrutinib Powder CAS 936563-96-1 Anti-Cancer Ibrutinib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A221
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Ibrutinib
• CAS: 936563-96-1
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Anti-Cancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Ibrutinib
Appearance	White Powder
CAS NO.	936563-96-1
Molecular Formula	C25H24N6O2
Storage	Keep in a cool, dry, dark location

Ibrutinib is an orally available, small-molecule inhibitor of Bruton's tyrosine kinase (BTK). It forms a covalent bond with the cysteine residue in the BTK active site, leading to irreversible inhibition of BTK activity.

1. Oncological Treatment: Approved by the U.S. Food and Drug Administration (FDA) for the treatment of mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). It is used as a monotherapy or in combination with other agents.
2. Research and Development: Utilized in preclinical and clinical research to investigate its therapeutic potential in various B-cell malignancies and autoimmune diseases.
3. Pharmaceutical Industry: Employed as a key active ingredient in the formulation of pharmaceutical products for the treatment of the aforementioned conditions.

1. Inhibition of BTK Activity: By covalently binding to the BTK active site, ibrutinib irreversibly inhibits BTK activity, thereby blocking the B-cell receptor (BCR) signaling pathway.
2. Suppression of Tumor Cell Growth and Survival: Inhibition of BTK activity disrupts the survival and proliferation of malignant B cells, leading to tumor cell apoptosis and reduction in tumor burden.
3. Modulation of Immune Response: Ibrutinib also affects the immune system by inhibiting the function of various immune cells, which may contribute to its therapeutic effects in autoimmune diseases.